Key Strategic Developments and Emerging Changes Shaping the Artificial Intelligence in Drug Repurposing Market Landscape

The artificial intelligence (AI) market in drug repurposing is positioned for remarkable expansion as healthcare and technology continue to intersect. Advancements in AI-driven tools are revolutionizing how existing medicines find new therapeutic uses, accelerating drug development timelines and improving patient outcomes. Let's explore the market's size, key players, driving forces, emerging trends, and the primary segments shaping this promising industry through 2030.

Projected Growth Trajectory of the Artificial Intelligence in Drug Repurposing Market
The artificial intelligence in drug repurposing market is forecasted to experience rapid growth, reaching a value of $2.63 billion by 2030. This expansion represents a compound annual growth rate (CAGR) of 20.1%. Several factors contribute to this surge, including the rising adoption of AI-assisted clinical decision support systems, increased utilization of generative AI for molecular analysis, urgent need for expedited drug repurposing during global health emergencies, broader application of real-world evidence analytics, and growing investments in precision medicine development pipelines. Key trends driving this market's momentum involve AI-powered drug-target matching using multi-omics datasets, knowledge graph-based repurposing pipelines, accelerated virtual screening and clinical trial simulations, federated learning enabling cross-institutional research collaboration, and explainable AI enhancing transparency in clinical repurposing decisions.

Download a free sample of the artificial intelligence in drug repurposing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29291&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Leading Organizations Steering the Artificial Intelligence in Drug Repurposing Market
A variety of influential companies shape the competitive landscape in this market, including IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., and Graph AI.
For example, in January 2024, Cosmos Health Inc., a US-based diversified healthcare firm, acquired Cloudscreen, a company specializing in AI-powered drug repurposing solutions. This strategic move aims to strengthen Cosmos Health's drug repurposing capabilities and speed up the discovery of novel therapeutic applications for existing medications.

Advancements in Technology Boosting Growth in AI Drug Repurposing
Companies in this market are increasingly embedding sophisticated computational drug repositioning systems that leverage AI, machine learning, and data mining techniques to uncover new uses for existing drugs by analyzing vast biological and literature data sources. These platforms enable a more systematic and data-driven approach to drug repurposing.
For instance, in November 2023, Tempus, a US-based provider of AI-powered precision medicine solutions, announced a strategic collaboration with Recursion Pharmaceuticals valued at up to $160 million over five years. This partnership grants Recursion access to Tempus' extensive set of de-identified oncology data, facilitating biomarker-driven therapeutic development. By combining Tempus' patient datasets with Recursion's AI capabilities, this collaboration exemplifies how integrating real-world clinical data with advanced AI technology can accelerate oncology drug repurposing efforts.

View the full artificial intelligence in drug repurposing market report:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-repurposing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Dominant Market Segments in Artificial Intelligence for Drug Repurposing
The artificial intelligence in drug repurposing market is segmented across several key dimensions:
1) Component: Software and Platforms, Services
2) Technology: Machine Learning or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs and Network-Based AI, Generative AI and Large Language Models (LLMs), Computer Vision
3) Deployment: Cloud-Based, On-Premises
4) Therapeutic Area: Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases
5) End-User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes, Healthcare Providers, Other End-Users

Subcategories include:
- Software and Platforms: Predictive Analytics Tools, Machine Learning Frameworks, Data Integration Systems, Drug Discovery Platforms, Clinical Trial Simulation Tools
- Services: Consulting Services, Data Management Services, Model Training and Optimization Services, Implementation and Integration Services, Support and Maintenance Services

This segmentation highlights the comprehensive range of technologies, applications, and users contributing to the rapid evolution of AI in drug repurposing.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.